January 27, 2021

The Niche

Trusted stem cell blog & resources


2 min read

The LA Times has an opinion piece out today by Michael Hiltzik criticizing CIRM. It’s deja vu all over again. The LA Times has shown itself to be very biased against CIRM over the years. Hiltzik specifically has been very hostile to the stem cell agency. I see their coverage of CIRM as unbalanced, never focusing on anything positive. CIRM recently got the ball rolling on significant changes to its structure, particularly as relates to its grant approval process, in response to a review of …Read More

1 min read

I just received a copy of CIRM’s proposed response to the IOM recommendations. Regarding what I believe to be the most important element, revamping the CIRM Board (aka ICOC), I was interested to see that CIRM (via President Jonathan Thomas) recommended that all institutional members of the Board no longer vote on whether to fund grants. To quote the CIRM response (full PDF here): Have 13 institutional members voluntarily abstain from voting on all grants brought before the Board for approval This is a very dramatic …Read More